诺华同意收购RNA疗法创新企业Avidity Biosciences,以强化其后期阶段的神经科学管线

动脉网
Nov 25, 2025

诺华宣布收购RNA疗法企业Avidity Biosciences,收购将在Avidity分拆早期心脏疾病项目后进行。Avidity致力于为严重遗传性神经肌肉疾病研发开创性RNA疗法——抗体-寡核苷酸偶联物(AOCs™),收购将把其后期神经科学项目纳入诺华,丰富其研发管线,推动神经科学战略发展。此次收购契合诺华深耕神经科学的战略,有望填补遗传性疾病治疗空白,扩展公司管线。Avidity项目包含潜在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10